No Data
No Data
No Data
No Data
No Data
Barclays Sticks to Its Hold Rating for Privia Health Group (PRVA)
TipRanksApr 15 04:26 ET
Privia Health Group, Inc. (NASDAQ:PRVA) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Privia Health Group (NASDAQ:PRVA) has had a rough month with its share price down 15%. However, stock prices are usually driven by a company's financials over the long term, which in this case look
Simply Wall StApr 10 08:19 ET
Privia Health to Report First Quarter 2024 Results on Thursday, May 9
Globe NewswireApr 9 09:00 ET
Analyst Scoreboard: 8 Ratings For Privia Health Gr
In the last three months, 8 analysts have published ratings on Privia Health Gr (NASDAQ:PRVA), offering a diverse range of perspectives from bullish to bearish.The table below provides a concise overv
BenzingaMar 19 11:01 ET
Canaccord Genuity Adjusts Privia Health Group Price Target to $37 From $41, Maintains Buy Rating
Privia Health Group (PRVA) has an average rating of Buy and price targets ranging from $21 to $37, according to analysts polled by Capital IQ.
MT NewswiresMar 19 08:27 ET
Privia Health Is Maintained at Buy by Canaccord Genuity
Privia Health Is Maintained at Buy by Canaccord Genuity
Dow JonesMar 19 06:56 ET
beaver Queen : why do directors sell their shares ?
70914791 beaver Queen: because they'd rather have $536,500,000.
shakaa Don : thanxxxxxx
BullRunner : Thanks for the heads up
No Data
No Data